Ziyi Wu

Ziyi Wu

Auto-generated profile, based on publicly available information

Ziyi Wu

Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2022 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
CLChang Li
Chang Li
ZWZiyi Wu
Ziyi Wu
HXHang Xue
Hang Xue
QGQiushi Gao
Qiushi Gao
YZYahan Zhang
Yahan Zhang
PZPing Zhao
Ping Zhao
Aims: Hypoxic–ischemic brain injury (HIBI) often results in cognitive impairments. Herein, we investigated the roles of ferroptosis in HIBI and the underlying signaling pathways.Methods: Ferrostatin‐1 (Fer‐1) or resveratrol (Res) treatments were administered intracerebroventricularly 30 min before HIBI in 7‐day‐old rats. Glutathione peroxidase 4 (GPx4) expression, malondialdehyde (MDA) concentration, iron content, mitochondrial morphology, and the expression of silent information regulator factor 2‐related enzyme 1 (SIRT1) and nuclear factor erythroid‐2‐related factor 2 (Nrf2) were measured after HIBI. Additionally, the weight ratio of left/right hemisphere, brain morphology, Nissl staining, and the Morris water maze test were conducted to estimate brain damage.Results: At 24‐h post‐HIBI, GPx4 expression was decreased, and MDA concentration and iron content were increased in the hippocampus. HIBI led to mitochondrial atrophy, brain atrophy/damage, and resultant learning and memory impairments, which were alleviated by Fer‐1‐mediated inhibition of ferroptosis. Furthermore, Res‐mediated SIRT1 upregulation increased Nrf2 and GPx4 expression, thereby attenuating ferroptosis, reducing brain atrophy/damage, and improving learning and memory abilities.Conclusion: The results demonstrated that during HIBI, ferroptosis occurs via the SIRT1/Nrf2/GPx4 signaling pathway, suggesting it as a potential therapeutic target for inhibiting ferroptosis and ameliorating HIBI‐induced cognitive impairments.

7 June 2023 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
QJQian Jiang
Qian Jiang
CWCong Wang
Cong Wang
QGQiushi Gao
Qiushi Gao
ZWZiyi Wu
Ziyi Wu
PZPing Zhao
Ping Zhao
Aims: Mid‐gestational sevoflurane exposure may induce notable long‐term neurocognitive impairment in offspring. This study was designed to investigate the role and potential mechanism of ferroptosis in developmental neurotoxicity induced by sevoflurane in the second trimester.Methods: Pregnant rats on day 13 of gestation (G13) were treated with or without 3.0% sevoflurane, Ferrostatin‐1 (Fer‐1), PD146176, or Ku55933 on three consecutive days. Mitochondrial morphology, ferroptosis‐relative proteins, malondialdehyde (MDA) levels, total iron content, and glutathione peroxidase 4 (GPX4) activities were measured. Hippocampal neuronal development in offspring was also examined. Subsequently, 15‐lipoxygenase 2 (15LO2)‐phosphatidylethanolamine binding protein 1 (PEBP1) interaction and expression of Ataxia telangiectasia mutated (ATM) and its downstream proteins were also detected. Furthermore, Morris water maze (MWM) and Nissl's staining were applied to estimate the long‐term neurotoxic effects of sevoflurane.Results: Ferroptosis mitochondria were observed after maternal sevoflurane exposures. Sevoflurane elevated MDA and iron levels while inhibiting GPX4 activity, and resultant long‐term learning and memory dysfunction, which were alleviated by Fer‐1, PD146176, and Ku55933. Sevoflurane could enhance 15LO2‐PEBP1 interaction and activate ATM and its downstream P53/SAT1 pathway, which might be attributed to excessive p‐ATM nuclear translocation.Conclusion: This study proposes that 15LO2‐mediated ferroptosis might contribute to neurotoxicity induced by maternal sevoflurane anesthesia during the mid‐trimester in the offspring and its mechanism may be ascribed to hyperactivation of ATM and enhancement of 15LO2‐PEBP1 interaction, indicating a potential therapeutic target for ameliorating sevoflurane‐induced neurotoxicity.

2 September 2020 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
HXHang Xue
Hang Xue
YZYa-Han Zhang
Ya-Han Zhang
QGQiu-Shi Gao
Qiu-Shi Gao
ZWZi-Yi Wu
Zi-Yi Wu
JNJia-Yuan Niu
Jia-Yuan Niu
PZPing Zhao
Ping Zhao

21 September 2023 in Journal of Anesthesia
Verified
Journal Article
Closed access
PDF file
FNFanshu Ni
Fanshu Ni
ZWZiyi Wu
Ziyi Wu
PZPing Zhao
Ping Zhao